Skip to main content
Signal8

CollPlant Biotechnologies Ltd (OPHI)

Sector: Orthopedic, Prosthetic & Surgical Appliances & Supplies

Industry: Medical - Specialties

CollPlant Biotechnologies Ltd. logo

CollPlant Biotechnologies Ltd.

NASDAQ:OPHIHealthcare
+17.17%$4.64
CLOSED
Mkt Cap$14.27M
EV-
Float1.25M
O/S3.08M
VOL27K sh
$ Vol$97K
RVOL0.36×
Inst Own-
SI2.9%
Net Cash/Sh-
Dilution
CollPlant Biotechnologies Ltd. logoNASDAQ:OPHIClosed$4.64+17.17%
Historical Data
DateOpenHighLowCloseVolume
Nov 17, 20263.553.813.463.6026,539
Nov 16, 20263.603.843.093.2861,945
Nov 13, 20264.104.283.603.65387,749
Nov 12, 20264.054.644.054.64439,303
Nov 11, 20264.034.203.863.9625,053
Nov 10, 20264.154.153.863.9022,145
Nov 9, 20264.004.293.764.2923,991
Nov 6, 20264.184.193.853.9729,217
Nov 5, 20264.134.253.943.94100,469
Nov 4, 20264.194.504.084.2336,177
Nov 3, 20264.014.443.994.1122,970
Nov 2, 20264.154.203.954.0840,495
Oct 30, 20264.204.604.104.1344,248
Oct 29, 20264.104.703.874.40167,097
Oct 28, 20263.874.003.753.959,250
Oct 27, 20263.783.963.633.9038,041
Oct 26, 20263.673.913.653.7533,811
Oct 23, 20263.603.723.523.6712,096
Oct 22, 20263.713.743.413.6210,600
Oct 21, 20263.803.813.553.759,684
Analyst Coverage
Analyst Coverage
ConsensusBuy
Price Target
Not available
Ratings Distribution
BUY
4
HOLD
1
SELL
0
TOTAL5
Insider Trades
InsiderTypeShares
Rotem Eran profile photoRotem EranGrant/Award510.4K
Abelis Bar Berta profile photoAbelis Bar BertaGrant/Award201.1K
Shareholders
--
Institutional
(8)
--
Insiderⓘ
(12)
--
5%+ Owners
(3)
--
Unattributed (incl. retail)ⓘ
Top Shareholders
NameShares%
Rotem Eran profile photo
Rotem Eran
Deputy CEO and CFO
516.4K--
The Loewenbaum 1992 Trust logo
The Loewenbaum 1992 Trust
· joint filing· may incl. warrants· filed Sep 2026
359.7K17.5%
Abelis Bar Berta profile photo
Abelis Bar Berta
VP Legal
206.4K--
Ami Sagy logo
Ami Sagy
· may incl. warrants· filed Oct 2026
163.7K5.7%
VILLERE ST DENIS J & CO LLC logo
VILLERE ST DENIS J & CO LLC
78.1K--
PINNACLE ASSOCIATES LTD logo
PINNACLE ASSOCIATES LTD
71.0K--
Shlomi Ruty Ben profile photo
Shlomi Ruty Ben
Director
66.5K--
Roumell Asset Management, LLC ("RAM") 52-2145132 logo
Roumell Asset Management, LLC ("RAM") 52-2145132
· may incl. warrants· stale · filed Feb 2024
43.3K3.8%
Evans Hugh M profile photo
Evans Hugh M
Director
31.6K--
JANE STREET GROUP, LLC logo
JANE STREET GROUP, LLC
23.1K--
Sources: 13F, Form 4, 13D/13G
Insiders & Institutional Holders
About

CollPlant Biotechnologies Ltd. is a regenerative and aesthetic medicine enterprise operating across the United States, Canada, and Europe.

The company primarily engages in the three-dimensional (3D) bioprinting of tissues and organs, alongside developing solutions for medical aesthetics. All of CollPlant's offerings are underpinned by its proprietary plant-based genetic engineering technology, which facilitates the production of recombinant type I human collagen.

Its diverse product portfolio encompasses BioInks engineered for 3D tissue and organ fabrication; dermal and soft tissue fillers designed to diminish wrinkles; and innovative breast implants, both 3D bioprinted and injectable, aimed at promoting breast tissue regeneration. CollPlant also provides a 3D bioprinted regenerative soft tissue matrix. Specialized products include VergenixSTR, a soft tissue repair matrix targeting tendinopathy, and VergenixFG, an advanced wound care treatment for deep surgical incisions and persistent wounds such as diabetic, venous, and pressure ulcers, burns, and bedsores.

The company maintains strategic collaboration agreements with numerous partners, including 3D Systems Corporation, CellInk (a BICO Group company), the Advanced Regenerative Manufacturing Institute, the RegenMed Development Organization, Israel's Technion Institute of Technology, AbbVie, and STEMCELL. Established in Rehovot, Israel, in 2004, the company was formerly known as CollPlant Holdings Ltd. before adopting its current name in June 2019.

Key Metrics
Market Cap$14.27M
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership--

based on 3.08M shares outstanding

SectorHealthcare
IndustryBiotechnology
ExchangeNASDAQ
CountryILIL
IPO DateJan 31, 2018
Shares Outstanding3.08M
Authorized Shares
Float1.25M
52-Week Range
$2.64$22.50
$4.64(10th percentile)
Volume
Average Daily Volume74.34K
439.10K today vs 74.34K avg(+491%)

30d Avg

74.34K

60d Avg

65.04K

90d Avg

396.15K

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...

Signal8's dilution snapshot of OPHI as of Dec 31, 2025 records an effective F-3 shelf registration (effective Jul 16, 2026), 12 outstanding warrant series and a PIPE closed Oct 14, 2026, from SEC filings. CollPlant Biotechnologies Ltd (NASDAQ: OPHI) traded at $4.64 on Nov 12, 2026, up 17.17% from the previous close of $3.96. 52-week range: $2.64 to $22.50. The company is in the Healthcare sector (Biotechnology).